• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

VULM 1457

CAS No. 228544-65-8

VULM 1457 ( —— )

产品货号. M27737 CAS No. 228544-65-8

VULM 1457 是一种有效的 ACAT 抑制剂。 VULM 1457 具有显着的降血脂活性,可改善整体心肌缺血再灌注损伤的结果。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥551 有现货
5MG ¥786 有现货
10MG ¥1320 有现货
25MG ¥2584 有现货
50MG ¥4682 有现货
100MG ¥6747 有现货
500MG ¥13689 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    VULM 1457
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    VULM 1457 是一种有效的 ACAT 抑制剂。 VULM 1457 具有显着的降血脂活性,可改善整体心肌缺血再灌注损伤的结果。
  • 产品描述
    VULM 1457 is a potent ACAT inhibitor. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes. VULM1457 significantly reduces production and secretion of adrenomedullin (AM) and down-regulates AM receptors on human hepatoblastic cells.(In Vitro):Preincubation of HepG2 cells with VULM1457 (0.1 μM) significantly reduced the specific [125I]AM binding on hypoxic cells with BmaxHypox being 127±10 and KD 0.06±0.11 nM. Preincubation of cells with VULM1457 (0.1 μM) significantly enhanced the number of cells (24.2±6 %) and higher concentrations of VULM1457 (1.0 and 10.0 μM) reduces the total number of cells. In HepG2 cell lines, VULM1457 (0.03 μM; 0.1 μM) significantly down-regulated specific AM receptors on HepG2 cells, and reduced AM secretion of HepG2 cells exposed to hypoxia. VULM1457 negatively regulates cell proliferation induced by AM.(In Vivo):In male Wistar rats, VULM 1457 protected the hearts of diabetic–hypercholesterolaemic rats against ischemia/reperfusion injury in vivo. VULM 1457 (50 mg/kg/day) significantly decreases plasma total cholesterol levels (1.7±0.1 mM vs. 2.9±0.5 mM in diabetic–hypercholesterolaemic animals). The hypolipidaemic effect of VULM 1457 is also observed in the liver of DM-HCH rats (3.9±0.2 mg/g vs. 7.4±1.0 mg/g).
  • 体外实验
    VULM1457 (0.03 and 0.1 μM) significantly down-regulates specific AM receptors on HepG2 cells, reduced AM secretion of HepG2 cells exposed to hypoxia.VULM1457 negatively regulates cell proliferation induced by AM.Preincubation of HepG2 cells with VULM1457 (0.1 μM) significantly reduces the total number of specific [125I]AM binding identified on cells at untouched affinity. Preincubation of HepG2 cells with high concentrations of VULM1457 (1.0 and 10.0 μM) significantly modifies the characteristics of binding of AM, i.e.Preincubation of HepG2 cells with VULM1457 (0.1 μM) significantly reduces the specific [125I]AM binding on hypoxic cells with BmaxHypox being 127±10 and KD 0.06±0.11 nM. Preincubation of cells with VULM1457 (0.1 μM) significantly enhances the number of cells (24.2±6 %) and higher concentrations of VULM1457 (1.0 and 10.0 μM) reduces the total number of cells. With the high concentrations of VULM1457 (1.0 and 10.0 μM), the reductions in [125I]AM specific binding on HepG2 cells is markedly attenuated.
  • 体内实验
    VULM 1457 significantly reduces atherogenic activity in animal experimental atherosclerosis.VULM 1457 protect the hearts of diabetic–hypercholesterolaemic rats against ischaemia/reperfusion injury in vivo.VULM 1457 (50 mg/kg/day; administered as an admixture to the fat-cholesterol diet for 5 days) significantly decreases plasma total cholesterol levels (1.7±0.1 mM vs. 2.9±0.5 mM in diabetic–hypercholesterolaemic animals). The hypolipidaemic effect of VULM 1457 is also observed in the liver of DM-HCH rats (3.9±0.2 mg/g vs. 7.4±1.0 mg/g). Animal Model:Male Wistar rats (250-300 g body weight), fed a standard diet and tap water ad libitum Dosage:50 mg/kg/day Administration:Administered as an admixture to the fat-cholesterol diet for 5 days Result:Improved the overall myocardial ischaemia-reperfusion injury outcomes in the diabetic-hypercholesterolaemic rats by suppressing arrhythmogenesis as well as by reducing myocardial necrosis, aside from remarkable hypolipidaemic activity.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    ——
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    228544-65-8
  • 分子量
    449.57
  • 分子式
    C25H27N3O3S
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 250 mg/mL (556.09 mM)
  • SMILES
    CC(C)c1cccc(C(C)C)c1NC(=O)Nc1ccc(Sc2ccc(cc2)[N+]([O-])=O)cc1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.C K Wilkins, et al. Volatile metabolites of some barley storage molds. Int J Food Microbiol. 1989 Feb;8(1):11-7.
产品手册
关联产品
  • Cyclic AMP

    环磷腺苷联合维生素C治疗小儿病毒性心肌炎疗效确切,可改善患者心功能,提高免疫功能。

  • 2,3-Dibromomaleinimi...

    2,3-Dibromomaleinimide 是在 Axinella brevistyla 中发现的海洋衍生天然产物。

  • Raspberry ketone glu...

    覆盆子酮葡萄糖苷是覆盆子果实中的天然产物,对抑制皮肤中黑色素生成及多种黑色素生成因子降解后具有持久作用。